Medical Device News Magazine

iCleanse Announces UV-C Product Licensing & Distribution Partnership with ChargeTech

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

March 2, 2021

iCleanse, the leader in UV-C personal device disinfection, today announces its partnership with ChargeTech, a leader in device management solutions, to combat the spread of COVID-19, expanding iCleanse’s UV-C disinfection product market reach across the Americas, Europe, and the Middle East.

ChargeTech will license iCleanse patents for ChargeTech’s existing suite of high capacity, UV-C Clean-Charge-Store Cabinets and Carts. This alliance allows iCleanse and ChargeTech to better serve the marketplace by offering the most comprehensive suite of patented chemical-free UV-C disinfection devices to combat 99.99% of pathogens, such as COVID-19.

iCleanse is the leader in chemical-free UV-C disinfection for mobile devices and the only patented solution. iCleanse’s partnership with ChargeTech will expand its reach into new markets beyond iCleanse’s industry-leading hospital network. ChargeTech’s connections with businesses across the country, in Europe, and the Middle East will help bring awareness to the power of UV-C and the importance of regularly disinfecting mobile phones and other devices to break the virus cycle.

“We are excited to announce iCleanse’s partnership with ChargeTech,” said Chris Allen, CEO of iCleanse. “They are an exceptional company of innovators with great products themselves. There is a great opportunity for us both to get our products out there to help businesses and communities battle COVID-19.”

iCleanse Product Line to be Distributed by ChargeTech

The iCleanse product line includes the Swift XL, Swift Mini, and Swift, which are engineered to control the disinfection process and adapt to a variety of venues, such as retail stores, restaurants, airports, and more.
The iCleanse product line includes:

  • iCleanse Swift XL: a patented chemical-free UV-C disinfection product for mobile devices and other personal items that kills 99.99% of pathogens, like COVID-19, in as little as 30 seconds. The Swift XL quickly disinfects multiple mobile phones and large-sized tablets simultaneously, as well as bulkier electronics and personal items, such as body cams, CB radios, stethoscopes, hairbrushes, and more. Simple to use, it comes equipped with an easy to navigate user interface to quickly start disinfection cycles or customize cycle times. The software includes notification when it’s time to replace the UV-C lamps, ensuring that devices are always properly disinfected.
  • iCleanse Swift and Swift Mini: are similar to the original popular Swift XL disinfection unit, but with a much smaller footprint. The small Swift Mini is only 15.5 inches wide and Swift is only 20 inches wide.  The Swift and Swift Mini are much more portable and versatile for hospitals and businesses without available space to sanitize devices.

“This partnership will enable us to better serve our existing corporate clients by expanding our product offering in this critically important category,” said ChargeTech CEO John Cappetta. “We were so impressed by the design and efficacy of the iCleanse products that we decided the best way to serve our customers was to expand on our large format suite of products by adding the iCleanse line or products as one of their licensed distributors. We are thrilled to expand on our CleanCharge line of large format UV-C device charging, cleaning, and storage products with the exceptional iCleanse products.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”